Smartwatch heart study aims to keep AFib patients out of hospital
NCT ID NCT07445789
Summary
This study aims to see if one of two common heart rate medications (verapamil or metoprolol) works better to control symptoms and prevent hospital visits for people with a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). It will also test if using a smartwatch to help patients manage their own medication leads to better results. The goal is to improve quality of life and reduce the need for emergency treatments and hospital stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.